1,076 Shares in CVS Health Co. (NYSE:CVS) Bought by Hara Capital LLC

Hara Capital LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,076 shares of the pharmacy operator’s stock, valued at approximately $68,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CVS. Norden Group LLC lifted its holdings in CVS Health by 10.7% in the first quarter. Norden Group LLC now owns 6,830 shares of the pharmacy operator’s stock valued at $545,000 after acquiring an additional 660 shares during the period. GSA Capital Partners LLP purchased a new position in shares of CVS Health in the first quarter valued at $536,000. Advisory Alpha LLC increased its position in shares of CVS Health by 9.6% in the first quarter. Advisory Alpha LLC now owns 3,753 shares of the pharmacy operator’s stock valued at $299,000 after buying an additional 329 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its position in shares of CVS Health by 15.8% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 148,361 shares of the pharmacy operator’s stock valued at $11,833,000 after buying an additional 20,264 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in shares of CVS Health by 341.8% in the first quarter. SG Americas Securities LLC now owns 203,103 shares of the pharmacy operator’s stock valued at $16,199,000 after buying an additional 157,133 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CVS shares. Wells Fargo & Company dropped their price target on CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a research report on Monday. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research report on Wednesday, September 4th. Mizuho dropped their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Finally, TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $73.00.

CVS Health Stock Down 7.3 %

Shares of NYSE:CVS opened at $57.11 on Friday. The firm has a market cap of $71.84 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 0.82 and a beta of 0.55. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The stock’s 50-day moving average price is $59.59 and its two-hundred day moving average price is $59.23.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.21 EPS. On average, research analysts forecast that CVS Health Co. will post 6.27 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.